NCT07274384

Hyperprogression in PD-L1 ≥ 50% NSCLC: a Biomarker Guided Phase 2 Trial

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: NOT_YET_RECRUITING

Phase: PHASE2

Sponsor: Università Vita-Salute San Raffaele

Condition: NSCLC (Non-small Cell Lung Cancer), Hyperprogression

Signal summary

Public flags

Status signal: Low Signal

Timeline signals: None

Results signal: Low Signal

Operational burden: strict_eligibility_signal

Stopped reason

Context when available

No stop reason available in the current public record.